Citation Tools

Download PDFPDF

Extended report
Patient-reported outcomes from a randomised phase III study of baricitinib in patients with rheumatoid arthritis and an inadequate response to biological agents (RA-BEACON)

Download to a citation manager

Cite this article as:
Smolen JS, Kremer JM, Gaich CL, et al
Patient-reported outcomes from a randomised phase III study of baricitinib in patients with rheumatoid arthritis and an inadequate response to biological agents (RA-BEACON)